Kansas City Life Insurance Company
KCLI
$30.97
-$1.04-3.25%
| Weiss Ratings | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.38 | |||
| Price History | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.18% | |||
| 30-Day Total Return | -14.09% | |||
| 60-Day Total Return | -14.28% | |||
| 90-Day Total Return | -13.81% | |||
| Year to Date Total Return | -13.02% | |||
| 1-Year Total Return | -13.34% | |||
| 2-Year Total Return | 44.40% | |||
| 3-Year Total Return | -21.63% | |||
| 5-Year Total Return | 28.63% | |||
| 52-Week High % Change | -17.92% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $39.00 | |||
| 52-Week Low Price | $32.01 | |||
| 52-Week Low Price (Date) | Mar 19, 2025 | |||
| 52-Week High Price (Date) | Aug 20, 2024 | |||
| Valuation | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 309.97M | |||
| Enterprise Value | 301.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.51 | |||
| Earnings Per Share Growth | -109.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.63 | |||
| Price/Book (Q) | 0.53 | |||
| Enterprise Value/Revenue (TTM) | 0.62 | |||
| Price | $30.97 | |||
| Enterprise Value/EBITDA (TTM) | -107.73 | |||
| Enterprise Value/EBIT | -47.72 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 9.68M | |||
| Dividend Yield | 1.75% | |||
| Div. Per Share (Most Recent) | $0.14 | |||
| Dividend Per Share (TTM) | $0.56 | |||
| Payout Ratio (TTM) | -109.22% | |||
| Dividend Per Share (Most Recent) | $0.14 | |||
| Company Info | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 816 753 7000 | |||
| Address | 3520 Broadway Kansas City, MO 64111-2565 | |||
| Website | www.kclife.com | |||
| Country | United States | |||
| Year Founded | 1895 | |||
| Profitability | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.28% | |||
| Profit Margin | -1.01% | |||
| Management Effectiveness | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.08% | |||
| Return on Equity | -- | |||
| Income Statement | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 485.77M | |||
| Total Revenue (TTM) | 490.79M | |||
| Revenue Per Share | $50.68 | |||
| Gross Profit (TTM) | 126.38M | |||
| EBITDA (TTM) | -2.80M | |||
| EBIT (TTM) | -6.33M | |||
| Net Income (TTM) | -4.97M | |||
| Net Income Avl. to Common (TTM) | -4.97M | |||
| Total Revenue Growth (Q YOY) | -37.86% | |||
| Earnings Growth (Q YOY) | -125.61% | |||
| EPS Diluted (TTM) | -0.51 | |||
| EPS Diluted Growth (Q YOY) | -125.61% | |||
| Balance Sheet | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 73.02M | |||
| Cash Per Share (Q) | $7.54 | |||
| Total Current Assets (Q) | 887.74M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 581.45M | |||
| Current Ratio (Q) | 15.788 | |||
| Book Value Per Share (Q) | $60.05 | |||
| Total Assets (Q) | 5.02B | |||
| Total Current Liabilities (Q) | 56.23M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 4.44B | |||
| Total Common Equity (Q) | 581.45M | |||
| Cash Flow | KCLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -13.01M | |||
| Cash from Financing (TTM) | 69.78M | |||
| Net Change in Cash (TTM) | -1.59M | |||
| Levered Free Cash Flow (TTM) | 103.32M | |||
| Cash from Operations (TTM) | -58.37M | |||
